Levomoprolol

Levomoprolol is a unique and specific type of drug classified as a beta adrenergic antagonist. As with many medications, its specific properties and effects are largely due to its structural orientation, specifically its designation as the (S)-enantiomer of moprolol.

Overview

Beta adrenergic antagonists, often termed "beta-blockers", are a class of drugs that impede the action of beta-adrenergic receptors in the body. These receptors play pivotal roles in the cardiovascular and pulmonary systems, among others. By antagonizing these receptors, drugs like Levomoprolol can influence heart rate, blood pressure, and other vital functions.

Enantiomer Specificity

Levomoprolol is the (S)-enantiomer of moprolol. In the realm of organic chemistry and drug design:

• Enantiomers: These are isomers, or molecules with the same molecular formula but different structural arrangements, which are mirror images of each other, much like left and right hands. Enantiomers often have different pharmacological effects due to their distinct spatial orientations.
• (S)-enantiomer: This denotes a specific orientation of the molecule, often with different properties than its mirror image, the (R)-enantiomer. In the case of moprolol, Levomoprolol represents this (S)-configuration.

Pharmacological Implications

While the overarching pharmacological action of Levomoprolol is as a beta-blocker, its enantiomeric specificity may give it unique properties compared to its (R)-enantiomer counterpart or the racemic mixture:

• Potency and Selectivity: The specific interactions and affinities of (S)-enantiomers for certain receptors might differ from those of the (R)-enantiomers. Thus, Levomoprolol could potentially have different potency or receptor selectivity compared to other forms of moprolol.
• Side Effect Profile: The different spatial orientation can also lead to varied interactions with off-target receptors or enzymes, potentially leading to a unique side effect profile.
• Metabolism and Excretion: Enantiomers can be metabolized differently in the body, potentially influencing drug half-life, excretion routes, and overall pharmacokinetics.

Summary

Levomoprolol, as the (S)-enantiomer of moprolol, presents a unique profile within the broader category of beta adrenergic antagonists. While its main action aligns with other beta-blockers, its specific enantiomeric form might confer unique pharmacological attributes that warrant further research and exploration.

   This article is a  stub. You can help WikiMD by expanding it!

Comprehensive list of medications or pharmaceutical drugs used in the United States with their NDC or national drug code, brand name, dosage, forms of administration etc. sorted alphabetically.

• Top 200 drugs
• Medicare drugs
• Canadian drugs
• Dictionary of drugs
• Encyclopedia of drugs
• List of FDA approved drugs
• List of drugs A-Z - sorted in multipage format
• Drug categories
• Drug dosage forms
• Habit forming drugs

External links

The following is the collection of detailed information and links to the National Institute of Health (NIH) comprehensive drug information portal and other reliable sources of information. Select the drug name below to show drug description, drug classification, other common drug names, and information on the reasons why prescribed, how medication should be used, and what possible side effects could occur.

Drug names

A • B • C • D • E • F • G • H • I • J • K • L • M • N • O • P • Q • R • S • T • U • V • W • X • Y • Z

Search for other drug names not listed above

Levomoprolol

• 

  Levomoprolol